Allogeneic stem cell transplantation as a curative therapeutic approach for VEXAS syndrome: a case report-Reference-Cited by-同舟云学术

Allogeneic stem cell transplantation as a curative therapeutic approach for VEXAS syndrome: a case report

Published:2022-01-09 Issue:2 Volume:57 Page:315-318
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Loschi Michael^ORCID,Roux Christian,Sudaka Isabelle,Ferrero-Vacher Corinne,Marceau-Renaut Alice,Duployez Nicolas,Passeron Thierry,Cluzeau Thomas^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

https://www.nature.com/articles/s41409-021-01544-y.pdf

Reference15 articles.

1. Beck DB, Ferrada MA, Sikora KA, Ombrello AK, Collins JC, Pei W, et al. Somatic Mutations in UBA1 and Severe Adult-Onset Autoinflammatory Disease. N Engl J Med. 2020;383:2628–38.

2. Obiorah IE, Patel BA, Groarke EM, Wang W, Trick M, Ombrello AK, et al. Benign and malignant hematologic manifestations in patients with VEXAS syndrome due to somatic mutations in UBA1. Blood Adv. 2021;5:3203–15.

3. Wang L, Raffoux E, Thomas X, Yakoub-Agha I, Bouhris J-H, de Botton S, et al. Immune stimulation during chemotherapy increases incidence of acute graft versus host disease in acute myeloid leukemia: a study on behalf of SFGM-TC and ALFA. Leuk Res. 2017;54:12–16.

4. Zeiser R, von Bubnoff N, Butler J, Mohty M, Niederwieser D, Or R, et al. Ruxolitinib for Glucocorticoid-Refractory Acute Graft-versus-Host Disease. N Engl J Med. 2020;382:1800–10.

5. Staels F, Betrains A. Woei-A-Jin FJSH, Boeckx N, Beckers M, Bervoets A et al. Case Report: VEXAS Syndrome: From Mild Symptoms to Life-Threatening Macrophage Activation Syndrome. Front Immunol. 2021;12:678927.

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of allogeneic hematopoietic cell transplantation in VEXAS syndrome;Annals of Hematology;2024-08-22

2. Skin Manifestations of VEXAS Syndrome and Associated Genotypes;JAMA Dermatology;2024-08-01

3. Long‐term genetic and clinical remissions after cessation of azacitidine treatment in patients with VEXAS syndrome;HemaSphere;2024-07-30

4. Assessing the efficacy of allogeneic hematopoietic cell transplantation in VEXAS syndrome: results of a systematic review and meta-analysis;Bone Marrow Transplantation;2024-07-26

5. A Case of VEXAS Syndrome Presenting Typical Symptons Diagnosed by Whole Exome Sequencing;The Nishinihon Journal of Dermatology;2024-06-01